Orexo (2 drugs' world rights) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Orexo (2 drugs' world rights) General Information

Description

Commercialization rights of Edluar and OX-NLA. It consists of the world wide distribution and marketing rights of the drugs Edluar and OX-NLA.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Distributors (Healthcare)
Other Business Products and Services
Acquirer
Meda
Primary Office
  • P.O. Box 303
  • 751 05 Uppsala
  • Sweden
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Orexo (2 drugs' world rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Orexo (2 drugs' world rights)‘s full profile, request access.

Request a free trial

Orexo (2 drugs' world rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Orexo (2 drugs' world rights)‘s full profile, request access.

Request a free trial